Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services. - Wikidata - awgldk - TriplyDB

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services.

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services.

http://www.wikidata.org/entity/Q52889724

about

Systemic lupus erythematosus: strategies to improve pregnancy outcomes Current and emerging treatment options in the management of lupus The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation Management of Difficult Cases of Autoimmune Hepatitis Genetic basis of congenital cardiovascular malformations Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity.Pregnancy outcomes in liver and cardiothoracic transplant recipients: a UK national cohort study.Pre-pregnancy counselling for women with chronic kidney disease: a retrospective analysis of nine years' experience.Hepatobiliary Quiz (Answers)-16 (2015).Contraceptive use in female recipients of a solid-organ transplant.Update on the Teratogenicity of Maternal Mycophenolate Mofetil.Breastfeeding and tacrolimus: is it a reasonable approach?Safety considerations when prescribing immunosuppression medication to pregnant women.Keys to long-term care of the liver transplant recipient.Why targeted therapies are necessary for systemic lupus erythematosus.A Review of the Course and Treatment of Non-Infectious Uveitis during Pregnancy.Management of pemphigus disease in pregnancy.Managing glomerular disease in pregnancy.Pregnancy Outcomes Related to Mycophenolate Exposure in Female Kidney Transplant Recipients.Editorial: Safety of immunosuppressive drugs in pregnant women with systemic inflammatory diseases.Treatment of canine meningoencephalomyelitis of unknown aetiology with mycophenolate mofetil and corticosteroids: 25 cases (2007-2012).Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.Intellectual performance of kidney transplant recipients' offspring: a cross-sectional, multicenter study.Changing of the guards: EMA warning on paternal use of mycophenolate mofetil: An unnecessary and insufficiently substantiated precaution.What Is the Teratogenic Risk of Mycophenolate?Mycophenolic Acid-Induced Developmental Defects in Zebrafish Embryos.Congenital Esophageal Atresia and Microtia in a Newborn Secondary to Mycophenolate Mofetil Exposure During Pregnancy: A Case Report and Review of the Literature.Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study

P2860

Q26741149-9318CFA5-592A-4E56-ACFA-DB4E7D418131 Q26741266-55D51DB3-B762-4050-899F-E75DBABD15EB Q26765038-DF95944E-CE28-4377-8B13-A802AAF8A584 Q33619600-75A854A3-2DE1-44CB-B120-D1B5FC4A21D5 Q34125381-94ACF952-1D8A-4C68-8AF0-CC17B074891B Q34805821-F97F36A2-53F3-47FF-9121-4F83D32AA268 Q35106744-914393C7-11F9-4D90-9993-F0B98E3B0CA5 Q35225608-5FDA95E1-0B1E-4448-BEDC-C8BEA1FA9986 Q36492514-06945948-C0A2-4107-AB6C-7A25637D11BC Q36848191-A1B53043-87B8-4416-82BD-565DCF2152DA Q37093346-7FE3DF61-F0D3-4E9B-9473-BAF39B8F1A70 Q38125241-5D6A1497-1760-45B0-B26D-E4FFD6E88555 Q38246109-BC642523-5166-4F0A-9DE3-88896EDA76CB Q38605687-4897591D-DF71-4054-B232-30D58A07F7CD Q38920435-EF9A0BCD-3595-4670-9847-A1741201C3DB Q38996685-230F24D4-7FF0-4481-BA31-91A9C7C8DE12 Q39013055-4F17C7C5-C842-49ED-B2A7-441227FAE284 Q39229290-1C3CBFF5-E74F-4CDC-9B3D-4AD05BDBD828 Q39671387-0322228A-59CA-42EB-B66C-5ADF710B214E Q42338695-502CD91F-FCF8-4EC6-998E-60034A924D30 Q42682690-62F436A8-1143-4546-ADF1-FDF4F854C41D Q46166151-9A83852B-3509-4C6E-901F-FCF4A90FA038 Q48227364-860660ED-04CB-4EC0-9B12-38993DD0DCC6 Q48286747-E3EA7154-4102-4BA1-AC8D-A9879198CDF7 Q50438358-60370E96-A2B2-457E-AB80-490E136CDCF5 Q50485528-625B98F2-44EF-41A4-B00F-D010EC3DC585 Q55008607-6A837C63-BBE9-4CF8-A57E-C60C631D1532 Q56964882-BF006D51-E01B-46F4-9D78-E34582F7BA65

P2860

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services.

http://www.wikidata.org/entity/Q52889724

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Teratogenicity of mycophenolat ...... ratology Information Services.

@en

Teratogenicity of mycophenolat ...... ratology Information Services.

@nl

type

label

Teratogenicity of mycophenolat ...... ratology Information Services.

@en

Teratogenicity of mycophenolat ...... ratology Information Services.

@nl

prefLabel

Teratogenicity of mycophenolat ...... ratology Information Services.

@en

Teratogenicity of mycophenolat ...... ratology Information Services.

@nl

P1433

Q52889724-A25F3C0B-386E-47C4-86F4-B632B8E7F42E

P1476

Q52889724-A2D8CC37-218A-49AE-B44F-39DDC4FD650E

P2093

Q52889724-4846D84D-2644-43A8-833D-CFFF248675B7

Q52889724-484E4348-CE9F-4BC7-B4CC-C881A5334F4E

Q52889724-5E1AAAA1-5320-4386-8E02-DCCA840A58F4

Q52889724-69272705-ABCB-43D5-8F6C-84C5280B613D

Q52889724-7BE939E4-7D36-4E96-8B05-AF9AC017852C

Q52889724-90464921-B54C-4EC7-8681-8BEACC5A858B

Q52889724-D7FB21AF-EDA1-4409-9BDD-72F6B9C23AFF

P2860

Q52889724-172B9EF4-A0B9-4C16-8709-629410BFCFE8

Q52889724-35DBCCA1-7B97-42F5-BC25-81C048761AC2

Q52889724-44A24C7D-7059-4B75-A37E-3C92B1AC5D02

Q52889724-4A39A35D-76B9-49C6-BA63-2810B9F3EA5B

Q52889724-5AEC691D-0B6E-4B02-95E5-DB610793D8D3

Q52889724-710B00C3-9BCE-4C9C-B15E-BE2D386F63C7

Q52889724-C3BAF174-3F4F-4BD5-BE6E-0E4ACD092B0A

Q52889724-DF22302C-54A3-4E13-AEBE-6846C9D6B1C5

Q52889724-E6906C1C-664E-4264-83A5-E58262F75641

Q52889724-F9260DFF-2EA0-4A46-89F4-80769E54AFC0

P304

Q52889724-D29EC2C2-30C7-42AF-A152-368067EB285E

P31

Q52889724-ECA4BE49-6CBD-497B-BDDD-3C81A22CBF2B

P356

Q52889724-FFAE75DB-C9DF-4E3D-8E31-5E4FAB1E44FF

P407

Q52889724-89AB0CFF-0111-41EB-8C29-57DC9A89D922

P433

Q52889724-559B5CF0-F2A2-4336-8C9D-31A1600AFC4F

P478

Q52889724-53FB4737-721D-42DF-AF7C-733E74EAFF61

P50

Q52889724-14139FC2-9478-4524-9D28-A7701532BFA9

Q52889724-D6B19DFA-9D75-4E0D-A1CD-A65B220BD300

P577

Q52889724-54846991-5F7E-4D93-BEE3-09F5A6B984BF

P698

Q52889724-01EF2875-80A1-455A-86C4-45904B670895

P921

Q52889724-9B4F9821-141D-40A0-AD1B-02A2B2B50FAE

P356

P1433

American Journal of Medical Genetics

P1476

Teratogenicity of mycophenolat ...... ratology Information Services.

@en

P2093

Arthur Allignol

http://www.w3.org/2001/XMLSchema#string

Christof Schaefer

http://www.w3.org/2001/XMLSchema#string

Corinna Weber-Schoendorfer

http://www.w3.org/2001/XMLSchema#string

Elisabeth Elefant

http://www.w3.org/2001/XMLSchema#string

Maurizio Clementi

http://www.w3.org/2001/XMLSchema#string

Sally Stephens

http://www.w3.org/2001/XMLSchema#string

Victoriya Finkel-Pekarsky

http://www.w3.org/2001/XMLSchema#string

P2860

A Systematic Review and Meta-Analysis of Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus and Lupus Nephritis

Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.

In utero exposure to immunosuppressive drugs: experimental and clinical studies.

Tetrada of the possible mycophenolate mofetil embryopathy: a review.

Selection bias in Teratology Information Service pregnancy outcome studies.

Statistical methods for estimating the probability of spontaneous abortion in observational studies--analyzing pregnancies exposed to coumarin derivatives.

Guidelines for case classification for the National Birth Defects Prevention Study.

Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus.

Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use.

Phenotypic abnormalities: Terminology and classification

P304

588-596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJMG.A.35223

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

158A

http://www.w3.org/2001/XMLSchema#string

P50

Maria Hoeltzenbein

P577

2012-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22319001

http://www.w3.org/2001/XMLSchema#string

P921